{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:42:16Z","timestamp":1770367336128,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03269-3","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:11:13Z","timestamp":1762888273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of Paclitaxel Injection Concentrate for Nanodispersion"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3519-7731","authenticated-orcid":false,"given":"Ajay J.","family":"Khopade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0273-7072","authenticated-orcid":false,"given":"Malay D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7663-492X","authenticated-orcid":false,"given":"Bhushan","family":"Borole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"3269_CR1","doi-asserted-by":"publisher","unstructured":"Khopade AJ, Shah MD, Borole B. A novel self-assembled paclitaxel nanodispersion facilitates rapid in-vitro\/in-vivo dissociation and protein binding. AAPS PharmSciTech. 2025;26(9). https:\/\/doi.org\/10.1208\/s12249-024-02996-3.","DOI":"10.1208\/s12249-024-02996-3"},{"key":"3269_CR2","doi-asserted-by":"crossref","unstructured":"Khopade AJ, Shah MD, Borole B, Burade V. Antitumor efficacy of paclitaxel injection concentrate for nanodispersion in patient-derived breast, head and neck, and non-small cell lung cancer mouse xenografts. AAPS PharmSciTech. 2025;26(5):150. (In-press).","DOI":"10.1208\/s12249-025-03153-0"},{"key":"3269_CR3","unstructured":"Taxol Package Insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020262s049lbl.pdf. Accessed 24 Apr 2025."},{"key":"3269_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37:1590\u20138. https:\/\/doi.org\/10.1016\/S0959-8049(01)00171-X.","journal-title":"Eur J Cancer"},{"issue":"3","key":"3269_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1548-5315(11)70224-8","volume":"6","author":"LD Irizarry","year":"2009","unstructured":"Irizarry LD, Luu TH, McKoy JM, Samaras AT, Fisher MJ, Carias EE, Raisch DW, Calhoun EA, Bennett CL. Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action. Community Oncol. 2009;6(3):132\u20134.","journal-title":"Community Oncol"},{"key":"3269_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/onco.13960","volume":"26","author":"R Barroso-Sousa","year":"2021","unstructured":"Barroso-Sousa R, Vaz-Luis I, Di Meglio A, Hu J, Li T, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, Partridge A, Burstein H, Waks AG, Tayob N, Trippa L, Tolaney SM, Hassett MJ, Winer EP, Lin NU. Prospective study testing a simplified Paclitaxel premedication regimen in patients with early breast cancer. Oncologist. 2021;26:927\u201333. https:\/\/doi.org\/10.1002\/onco.13960.","journal-title":"Oncologist"},{"issue":"32","key":"3269_CR7","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1200\/JCO.21.01200","volume":"39","author":"OM Lansinger","year":"2021","unstructured":"Lansinger OM, Biedermann S, He Z, Colevas AD. Do steroids matter? A retrospective review of premedication for taxane chemotherapy and hypersensitivity reactions. J Clin Oncol. 2021;39(32):3583\u201390. https:\/\/doi.org\/10.1200\/JCO.21.01200.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3269_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.bjc.6690696","volume":"81","author":"O van Tellingen","year":"1999","unstructured":"van Tellingen O, Huizing MT, Panday VR, Schellens JH, Nooijen WJ, Beijnen JH. Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients. Br J Cancer. 1999;81(2):330\u20135.","journal-title":"Br J Cancer"},{"issue":"9","key":"3269_CR9","first-page":"2112","volume":"56","author":"A Sparreboom","year":"1996","unstructured":"Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res. 1996;56(9):2112\u20135.","journal-title":"Cancer Res"},{"key":"3269_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1078155206073589","volume":"12","author":"P Donyai","year":"2006","unstructured":"Donyai P, Sewell GJ. Physical and chemical stability of paclitaxel infusions in different container types. J Oncol Pharm Pract. 2006;12:211\u201322. https:\/\/doi.org\/10.1177\/1078155206073589.","journal-title":"J Oncol Pharm Pract"},{"key":"3269_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0378-5173(95)04128-1","volume":"127","author":"MC Allwood","year":"1996","unstructured":"Allwood MC, Martin H. The extraction of diethyl hexylphthalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection. Int J Pharm. 1996;127:65\u201371.","journal-title":"Int J Pharm"},{"issue":"7","key":"3269_CR12","first-page":"1520","volume":"48","author":"WN Waugh","year":"1991","unstructured":"Waugh WN, Trissel LA, Stella VJ. Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm. 1991;48(7):1520\u20134.","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"3269_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000327368","volume":"57","author":"I Bononi","year":"2011","unstructured":"Bononi I, Forgetta C, Baldisserotto A, Tognon M. Simulated infusion of paclitaxel with in-line filters. Chemotherapy. 2011;57(3):204\u20138.","journal-title":"Chemotherapy"},{"key":"3269_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/IJN.S3061","volume":"4","author":"E Miele","year":"2009","unstructured":"Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane\u00ae ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99\u2013105. https:\/\/doi.org\/10.2147\/IJN.S3061.","journal-title":"Int J Nanomedicine"},{"key":"3269_CR15","unstructured":"Abraxane pack insert 25\/08\/2020\/Suppl-47. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021660s047lbl.pdf.\u00a0Accessed 24 Apr 2025"},{"key":"3269_CR16","doi-asserted-by":"publisher","first-page":"19736","DOI":"10.1021\/acsami.1c03065","volume":"13","author":"M Hama","year":"2021","unstructured":"Hama M, Ishima Y, Chuang VTG, Ando H, Shimizu T, Ishida T. Evidence for delivery of Abraxane via a denatured-albumin transport system. ACS Appl Mater Interfaces. 2021;13:19736\u201344. https:\/\/doi.org\/10.1021\/acsami.1c03065.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3269_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1078155214556008","volume":"22","author":"G Dranitsaris","year":"2016","unstructured":"Dranitsaris G, Yu B, Wang L, Sun W, Zhou Y, King J, Kaura S, Zhang A, Yuan P. Abraxane\u00ae versus Taxol\u00ae for patients with advanced breast cancer: a prospective time and motion analysis from a Chinese health care perspective. J Oncol Pharm Pract. 2016;22(2):205\u201311.","journal-title":"J Oncol Pharm Pract"},{"issue":"31","key":"3269_CR18","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"WJ Gradishar","year":"2005","unstructured":"Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O\u2019Shaughnessy J. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol. 2005;23(31):7794\u2013803.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3269_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","volume":"12","author":"N Desai","year":"2006","unstructured":"Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006;12(4):1317\u201324.","journal-title":"Clin Cancer Res"},{"key":"3269_CR20","unstructured":"Desai N, Yao Z, Trieu V. Evidence of a novel transporter mechanism for a Cremophorfree, protein-engineered paclitaxel (ABI-007) and enhanced in vivo antitumor activity in an MX-1 human breast tumor xenograft model. 25th Annual San Antonio Breast Conference Symposium, San Antonio, TX; 2002. pp. 11\u201314."},{"issue":"2","key":"3269_CR21","doi-asserted-by":"publisher","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","volume":"4","author":"P Ma","year":"2013","unstructured":"Ma P, Mumper RJ. Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol. 2013;4(2):1000164.","journal-title":"J Nanomed Nanotechnol"},{"issue":"122","key":"3269_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.addr.2017.02.003","volume":"1","author":"AM Sofias","year":"2017","unstructured":"Sofias AM, Dunne M, Storm G, Allen C. The battle of \u201cnano\u201d paclitaxel. Adv Drug Deliv Rev. 2017;1(122):20\u201330.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"3269_CR23","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","volume":"18","author":"DW Kim","year":"2007","unstructured":"Kim DW, Kim SY, Kim HK, et al. Multicenter phase II trial of Genexol-PM, a novel cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007;18(12):2009\u201314.","journal-title":"Ann Oncol"},{"issue":"15","key":"3269_CR24","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.2147\/IJN.S272529","volume":"22","author":"RAG van Eerden","year":"2020","unstructured":"van Eerden RAG, Mathijssen RHJ, Koolen SLW. Recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Int J Nanomedicine. 2020;22(15):8151\u201366.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3269_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12885-024-11860-3","volume":"24","author":"R Li","year":"2024","unstructured":"Li R, Liang H, Li J, Shao Z, Yang D, Bao J, Wang K, Xi W, Gao Z, Guo R, Mu X. Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study. BMC Cancer. 2024;24(1):107.","journal-title":"BMC Cancer"},{"key":"3269_CR26","unstructured":"Summary of product characteristics for Apealea 60 mg powder for solution for infusion. https:\/\/ec.europa.eu\/health\/documents\/community-register\/2020\/20200813149025\/anx_149025_en.pdf. Accessed 24 Apr 2025"},{"key":"3269_CR27","doi-asserted-by":"crossref","unstructured":"Siram K, Rahman SH, Balakumar K, Duganath N, Chandrasekar R, Hariprasad R. Chapter 4 - pharmaceutical nanotechnology: brief perspective on lipid drug delivery and its current scenario. In: Grumezescu AM, editor. Biomedical applications of nanoparticles. William Andrew Publishing; 2019. pp 91\u2013115.","DOI":"10.1016\/B978-0-12-816506-5.00005-X"},{"key":"3269_CR28","doi-asserted-by":"crossref","unstructured":"Lichtenstein AH. Lipids (fats and oils). In: Caballero B, editor. Encyclopedia of human nutrition. 4th ed. Academic Press; 2023. pp. 291\u2013300.","DOI":"10.1016\/B978-0-12-821848-8.00013-5"},{"key":"3269_CR29","doi-asserted-by":"publisher","unstructured":"Kontogiorgos V. Lipids. In: Introduction to food chemistry. Cham: Springer; 2021. https:\/\/doi.org\/10.1007\/978-3-030-85642-7_4.","DOI":"10.1007\/978-3-030-85642-7_4"},{"issue":"10","key":"3269_CR30","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/molecules23102583","volume":"23","author":"CCCR de Carvalho","year":"2018","unstructured":"de Carvalho CCCR, Caramujo MJ. The various roles of fatty acids. Molecules. 2018;23(10):2583.","journal-title":"Molecules"},{"key":"3269_CR31","doi-asserted-by":"publisher","unstructured":"Waisundara Y. Introductory chapter: fatty acids in modern times. Biochemistry and health benefits of fatty acids. IntechOpen; 2018. https:\/\/doi.org\/10.5772\/intechopen.82440.","DOI":"10.5772\/intechopen.82440"},{"issue":"1\u20132","key":"3269_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3989\/gya.2000.v51.i1-2.409","volume":"51","author":"AM Rabasco Alvarez","year":"2000","unstructured":"Rabasco Alvarez AM, Gonz\u00e1lez Rodr\u00edguez ML. Lipids in pharmaceutical and cosmetic preparations. Grasas Aceites. 2000;51(1\u20132):74\u201396.","journal-title":"Grasas Aceites"},{"issue":"7","key":"3269_CR33","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2174\/1573412916999200605162707","volume":"17","author":"L Zheng","year":"2021","unstructured":"Zheng L, Shen X, Wang Y, Liang J, Xu M, Fang X, Chen G, Chen G. Content and composition of phospholipids, fatty acids and sterols in commercial natural phospholipid excipients. Curr Pharm Anal. 2021;17(7):892\u2013902.","journal-title":"Curr Pharm Anal"},{"issue":"11","key":"3269_CR34","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/pharmaceutics14112386","volume":"14","author":"A Budiman","year":"2022","unstructured":"Budiman A, Citraloka ZG, Muchtaridi M, Sriwidodo S, Aulifa DL, Rusdin A. Inhibition of crystal nucleation and growth in aqueous drug solutions: impact of different polymers on the supersaturation profiles of amorphous drugs-the case of Alpha-Mangostin. Pharmaceutics. 2022;14(11): 2386.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3269_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/pharmaceutics16050630","volume":"16","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li X, Liu B, Kong J, Wang Q, Gao Z. Using polymers as crystal inhibitors to prevent the crystallization of the Rotigotine patch. Pharmaceutics. 2024;16(5): 630.","journal-title":"Pharmaceutics"},{"key":"3269_CR36","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1039\/c2ce25515d","volume":"14","author":"GA Ilevbare","year":"2012","unstructured":"Ilevbare GA, Liu H, Edgar KJ, Taylor LS. Inhibition of solution crystal growth of ritonavir by cellulose polymers \u2013 factors influencing polymer effectiveness. Cryst Eng Comm. 2012;14:6503\u201314.","journal-title":"Cryst Eng Comm"},{"issue":"7","key":"3269_CR37","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/jps.23588","volume":"102","author":"S Ozaki","year":"2013","unstructured":"Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs. J Pharm Sci. 2013;102(7):2273\u201381.","journal-title":"J Pharm Sci"},{"key":"3269_CR38","doi-asserted-by":"publisher","first-page":"121538","DOI":"10.1016\/j.ijpharm.2022.121538","volume":"616","author":"P Zhao","year":"2022","unstructured":"Zhao P, Hu G, Chen H, Li M, Wang Y, Sun N, Wang L, Xu Y, Xia J, Tian B, Liu Y, He Z, Fu Q. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: a case of nimodipine. Int J Pharm. 2022;616: 121538.","journal-title":"Int J Pharm"},{"key":"3269_CR39","doi-asserted-by":"publisher","first-page":"133830","DOI":"10.1016\/j.foodchem.2022.133830","volume":"397","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Liu F, Liu L, Qiu X, Ye M, Pan H, Liu H. Effects of length and type of the alkyl chain on the micellization behavior of mixed systems of HS15 with fatty acids. Food Chem. 2022;397:133830.","journal-title":"Food Chem"},{"issue":"7","key":"3269_CR40","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.bpj.2014.07.067","volume":"107","author":"I Budin","year":"2014","unstructured":"Budin I, Prwyes N, Zhang N, Szostak JW. Chain-length heterogeneity allows for the assembly of fatty acid vesicles in dilute solutions. Biophys J. 2014;107(7):1582\u201390.","journal-title":"Biophys J"},{"key":"3269_CR41","unstructured":"SMOFLIPID Package Insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207648s005lbl.pdf.\u00a0Accessed 24 Apr 2025."},{"key":"3269_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1248\/cpb.59.321","volume":"59","author":"XJ Xia","year":"2011","unstructured":"Xia XJ, Guo RF, Liu YL, Zhang PX, Zhou CP, Jin DJ, Wang RY. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex. Chem Pharm Bull (Tokyo). 2011;59:321\u20136. https:\/\/doi.org\/10.1248\/cpb.59.321.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"1","key":"3269_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/la503644m","volume":"31","author":"CJ Schram","year":"2015","unstructured":"Schram CJ, Beaudoin SP, Taylor LS. Impact of polymer conformation on the crystal growth inhibition of a poorly water-soluble drug in aqueous solution. Langmuir. 2015;31(1):171\u20139.","journal-title":"Langmuir"},{"issue":"6","key":"3269_CR44","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1021\/cg300325p","volume":"12","author":"GA Ilevbare","year":"2012","unstructured":"Ilevbare GA, Liu H, Edgar KJ, Taylor LS. Understanding polymer properties important for crystal growth inhibition\u2014impact of chemically diverse polymers on solution crystal growth of Ritonavir. Cryst Growth Des. 2012;12(6):3133\u201343.","journal-title":"Cryst Growth Des"},{"issue":"3","key":"3269_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1742-481X.2007.00405.x","volume":"5","author":"P Durani","year":"2008","unstructured":"Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J. 2008;5(3):376\u201387.","journal-title":"Int Wound J"},{"issue":"Suppl A","key":"3269_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0195-6701(85)80054-2","volume":"6","author":"WF Sindelar","year":"1985","unstructured":"Sindelar WF, Brower ST, Merkel AB, Takesue EI. Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intra-abdominal infectious complications. J Hosp Infect. 1985;6(Suppl A):103\u201314.","journal-title":"J Hosp Infect"},{"key":"3269_CR47","doi-asserted-by":"publisher","first-page":"13475","DOI":"10.1002\/anie.201607117","volume":"55","author":"D Garenne","year":"2016","unstructured":"Garenne D, Beven L, Navailles L, Nallet F, Dufourc EJ, Douliez JP. Sequestration of proteins by fatty acid coacervates for their encapsulation within vesicles. Angew Chem Int Ed Engl. 2016;55:13475\u20139. https:\/\/doi.org\/10.1002\/anie.201607117.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3269_CR48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.31635\/ccschem.021.202000702","volume":"3","author":"L Zhou","year":"2021","unstructured":"Zhou L, Fan Y, Liu Z, Chen L, Spruijt E, Wang Y. A multiresponsive transformation between surfactant-based coacervates and vesicles. CCS Chem. 2021;3:358\u201366.","journal-title":"CCS Chem"},{"key":"3269_CR49","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1021\/bi101334j","volume":"49","author":"SC Howell","year":"2010","unstructured":"Howell SC, Fraser NJ, Mittal R, Huang L, Travis B, Breyer RM, Sanders CR. Erratum: CHOBIMALT: A cholesterol-based detergent. Biochem. 2010;49:9572\u201383. https:\/\/doi.org\/10.1021\/bi101334j.","journal-title":"Biochem"},{"key":"3269_CR50","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00280-021-04235-z","volume":"87","author":"WW Ma","year":"2021","unstructured":"Ma WW, Zhu M, Lam ET, Diamond JR, Dy GK, Fisher GA, Goff LW, Alberts S, Bui LA, Sanghal A, Kothekar M, Khopade A, Chimote G, Faulkner R, Eckhardt SG, Adjei AA, Jimeno A. A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers. Cancer Chemother Pharmacol. 2021;87:779\u201388.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3269_CR51","doi-asserted-by":"publisher","first-page":"103156","DOI":"10.1016\/j.cis.2024.103156","volume":"327","author":"L Caselli","year":"2024","unstructured":"Caselli L, Conti L, Santis ID, Berti D. Small-angle X-ray and neutron scattering applied to lipid-based nanoparticles: recent advancements across different length scales. Adv Colloid Interface Sci. 2024;327: 103156.","journal-title":"Adv Colloid Interface Sci"},{"key":"3269_CR52","unstructured":"Monograph: USP. Paclitaxel. In: USP 30\u2013NF 25. Rockville: USP. p. 2844."},{"key":"3269_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-016-3736-9","volume":"156","author":"MM Jain","year":"2016","unstructured":"Jain MM, Gupte SU, Patil SG, Pathak AB, Deshmukh CD, Bhatt N, Haritha C, Govind Babu K, Bondarde SA, Digumarti R, Bajpai J, Kumar R, Bakshi AV, Bhattacharya GS, Patil P, Subramanian S, Vaid AK, Desai CJ, Khopade A, Chimote G, Bapsy PP, Bhowmik S. Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II\/III study. Breast Cancer Res Treat. 2016;156:125\u201334.","journal-title":"Breast Cancer Res Treat"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03269-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:05:44Z","timestamp":1770314744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03269-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03269-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors were employees of Sun Pharma Advanced Research Company who sponsored the project. The authors declare no other known competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"25"}}